Juan Francisco Delgado Jimenez
Overview
Explore the profile of Juan Francisco Delgado Jimenez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
22
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garcia-Cosio M, Cruzado J, Farrero M, Blasco Peiro M, Crespo M, Delgado Jimenez J, et al.
Rev Esp Cardiol (Engl Ed)
. 2024 Oct;
78(3):252-262.
PMID: 39442797
Renal transplantation improves the survival and quality of life of patients with end-stage renal disease. Cardiovascular disease is the leading cause of morbidity and mortality in renal transplant recipients. The...
2.
de Miguel-Diez J, Villota J, Santos Perez S, Manito Lorite N, Navarrete B, Delgado Jimenez J, et al.
Arch Bronconeumol
. 2024 Feb;
60(4):226-237.
PMID: 38383272
Chronic obstructive pulmonary disease (COPD) and cardiovascular disease (CVD) frequently coexist, increasing the prevalence of both entities and impacting on symptoms and prognosis. CVD should be suspected in patients with...
3.
Lopez-Azor J, De la Torre N, Garcia-Cosio Carmena M, Caravaca Perez P, Munera C, MarcoClement I, et al.
Card Fail Rev
. 2022 May;
8:e13.
PMID: 35516795
Telemonitoring through multiple variables measured on cardiac devices has the potential to improve the follow-up of patients with heart failure. The HeartLogic algorithm (Boston Scientific), implemented in some implantable cardiac...
4.
Garcia Perez J, Jimenez Almonacid J, Palomino Doza A, Delgado Jimenez J, Enguita Valls A
Rev Esp Patol
. 2021 Mar;
54(2):127-131.
PMID: 33726889
Non-compacted myocardiopathy is rare, the prevalence ranging between 0.01-0.26%. in adults. We present the macroscopic, microscopic and electron microscopy findings of cardiac transplant samples from a 36-year-old patient diagnosed with...
5.
Manito Lorite N, Rubio-Rodriguez D, Costello J, Diez Lopez C, Enjuanes Grau C, Segovia-Cubero J, et al.
Rev Esp Cardiol (Engl Ed)
. 2020 Jan;
73(5):361-367.
PMID: 31899185
Introduction And Objectives: Advanced heart failure (HF) leads to high hospitalization and mortality rates. The LION-HEART study was a randomized, placebo-controlled clinical trial that evaluated the safety and efficacy of...
6.
Trends in Pulmonary Hypertension Over a Period of 30 Years: Experience From a Single Referral Centre
Quezada Loaiza C, Velazquez Martin M, Lopez-Guarch C, Ruiz Cano M, Navas Tejedor P, Carreira P, et al.
Rev Esp Cardiol (Engl Ed)
. 2017 Apr;
70(11):915-923.
PMID: 28454887
Introduction And Objectives: Pulmonary arterial hypertension (PAH) is characterized by increased pulmonary vascular resistance, right ventricular dysfunction and death. Despite scientific advances, is still associated with high morbidity and mortality....
7.
Gomez-Sanchez M, Saenz de la Calzada C, Escribano Subias P, Delgado Jimenez J, Lazaro Salvador M, Albarran Gonzalez A, et al.
Eur J Heart Fail
. 2004 Aug;
6(5):615-7.
PMID: 15302010
Objective: To determine the acute vasodilator effect of sublingual sildenafil in heart transplant candidates with severe pulmonary hypertension due to severe left ventricular dysfunction (LVD). Background: Pulmonary hypertension confers an...